Insider Trading activities at Chemocentryx, Inc. (CCXI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chemocentryx, Inc. (CCXI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chemocentryx, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1340652.

Total stock buying since 2014: $822,817.
Total stock sales since 2014: $493,099,090.
Total stock option exercises since 2014: $39,017,290.


 1   2 
19 insiders reported insider trading activities at Chemocentryx, Inc. (CCXI):
Insider trading activities of Butt Tausif
Insider trading activities of Kanaya Susan M
Insider trading activities of Duliege Anne-marie
Insider trading activities of Vifor Fresenius Medical Care Renal Pharma Ltd.
Insider trading activities of Bvf Investments Llc
Insider trading activities of Glaxosmithkline Plc
Insider trading activities of Jain Rita
Insider trading activities of Lucas Roger C
Insider trading activities of Klein Ira
Insider trading activities of Schall Thomas J.
Insider trading activities of Kwan Pui San
Insider trading activities of Mckinnell Henry A
Insider trading activities of Parker Geoffrey M.
Insider trading activities of Bekker Petrus
Insider trading activities of Cappel Markus J.
Insider trading activities of Feczko Joseph M
Insider trading activities of Edwards Thomas A.
Insider trading activities of Singh Rajinder
Insider trading activities of Tyree James L

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Chemocentryx, Inc. (CCXI).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2022 0 $0 217,623 $10,850,501 418,318 $3,118,706
2021 10,870 $120,243 4,146,580 $165,921,075 283,689 $1,623,120
2020 0 $0 3,284,957 $172,024,009 1,873,059 $18,059,132
2019 0 $0 1,276,330 $33,885,168 1,672,848 $10,320,049
2018 0 $0 8,037,090 $94,247,953 874,942 $4,101,193
2017 0 $0 198,470 $1,818,895 405,129 $1,221,027
2016 135,000 $557,645 158,506 $987,327 198,909 $454,067
2015 20,000 $144,929 1,602,727 $13,340,729 335,135 $119,996
2014 0 $0 4,970 $23,433 0 $0

Table 2. Monthly summary of insider trading at Chemocentryx, Inc. (CCXI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2022-08 0 $0 213,760 $10,750,311 196,196 $2,369,956
2022-06 0 $0 3,863 $100,190 0 $0
2022-05 0 $0 0 $0 43,404 $180,250
2022-03 0 $0 0 $0 5,251 $0
2022-01 0 $0 0 $0 173,467 $568,500
2021-12 0 $0 37,500 $1,297,087 83,436 $1,071,553
2021-10 0 $0 4,000,000 $157,720,000 0 $0
2021-05 10,870 $120,243 0 $0 0 $0
2021-03 0 $0 69,449 $4,375,635 41,690 $348,871
2021-02 0 $0 34,072 $2,164,222 13,672 $148,278
2021-01 0 $0 5,559 $364,131 144,891 $54,418
2020-12 0 $0 105,322 $6,757,314 80,322 $874,786
2020-08 0 $0 49,258 $2,645,450 0 $0
2020-07 0 $0 1,433,482 $81,919,632 0 $0
2020-06 0 $0 174,294 $11,318,526 185,044 $2,202,014
2020-05 0 $0 305,198 $17,215,479 320,646 $2,912,751
2020-03 0 $0 70,844 $3,149,149 46,095 $584,477
2020-02 0 $0 536,703 $25,404,334 517,762 $6,219,056
2020-01 0 $0 609,856 $23,614,125 723,190 $5,266,048
2019-12 0 $0 0 $0 141,268 $1,144,851
2019-11 0 $0 921,315 $29,271,145 921,315 $7,308,926
2019-10 0 $0 0 $0 33,334 $0
2019-05 0 $0 12,815 $153,805 43,273 $108,060
2019-04 0 $0 187,245 $2,542,743 187,245 $994,770

Table 3. Detailed insider trading at Chemocentryx, Inc. (CCXI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-08-16 Kanaya Susan M (EVP, CFO and Sec.) Sale 19,898 50.95 1,013,803
2022-08-16 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 19,898 10.86 216,092
2022-08-04 Schall Thomas J. (President and CEO) Sale 130,000 50.24 6,531,720
2022-08-04 Schall Thomas J. (President and CEO) Option Ex 130,000 14.28 1,856,400
2022-08-04 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 7,564 50.22 379,864
2022-08-04 Tyree James L (Director) Sale 10,000 50.22 502,200
2022-08-04 Kanaya Susan M (EVP, CFO and Sec.) Sale 46,298 50.17 2,322,724
2022-08-04 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 46,298 6.42 297,464
2022-06-09 Tyree James L (Director) Sale 3,863 25.94 100,190
2022-05-20 Jain Rita (EVP, Chief Medical Officer) Option Ex 7,726 .00 0
2022-05-20 Parker Geoffrey M. (Director) Option Ex 7,726 .00 0
2022-05-20 Tyree James L (Director) Option Ex 7,726 .00 0
2022-05-20 Mckinnell Henry A (Director) Option Ex 7,726 .00 0
2022-05-02 Parker Geoffrey M. (Director) Option Ex 12,500 14.42 180,250
2022-03-27 Jain Rita (EVP, Chief Medical Officer) Option Ex 5,251 .00 0
2022-01-21 Feczko Joseph M (Director) Option Ex 37,500 15.16 568,500
2022-01-01 Schall Thomas J. (President and CEO) Option Ex 84,234 .00 0
2022-01-01 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 20,934 .00 0
2022-01-01 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 30,799 .00 0
2021-12-17 Tyree James L (Director) Sale 37,500 34.59 1,297,087
2021-12-17 Tyree James L (Director) Option Ex 37,500 13.52 507,000
2021-12-01 Schall Thomas J. (President and CEO) Option Ex 45,936 12.29 564,553
2021-10-12 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 4,000,000 39.43 157,720,000
2021-05-07 Butt Tausif (EVP, Chief Operating Officer) Buy 10,870 11.06 120,243
2021-03-27 Jain Rita (Director) Option Ex 5,251 .00 0
2021-03-05 Parker Geoffrey M. (Director) Sale 30,000 56.33 1,689,990
2021-03-04 Parker Geoffrey M. (Director) Sale 1,910 60.20 114,980
2021-03-02 Edwards Thomas A. (Director) Sale 1,100 70.06 77,060
2021-03-01 Kwan Pui San (Principal Acctg Officer) Sale 3,347 68.48 229,219
2021-03-01 Kwan Pui San (Principal Acctg Officer) Option Ex 3,347 10.31 34,497
2021-03-01 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 33,092 68.43 2,264,386
2021-03-01 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 33,092 9.50 314,374
2021-02-09 Edwards Thomas A. (Director) Sale 400 70.03 28,014
2021-02-09 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 700 69.66 48,764
2021-02-09 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 700 11.02 7,714
2021-02-08 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 7,420 67.64 501,881
2021-02-08 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 7,420 11.02 81,768
2021-02-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 805 67.07 53,994
2021-02-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 805 11.02 8,871
2021-02-04 Kwan Pui San (Principal Acctg Officer) Sale 3,347 65.00 217,555
2021-02-04 Kwan Pui San (Principal Acctg Officer) Option Ex 3,347 10.31 34,497
2021-02-04 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,400 67.14 93,994
2021-02-04 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,400 11.02 15,428
2021-02-02 Edwards Thomas A. (Director) Sale 20,000 61.00 1,220,020
2021-01-25 Kwan Pui San (Principal Acctg Officer) Sale 4,184 65.00 271,960
2021-01-25 Kwan Pui San (Principal Acctg Officer) Option Ex 4,184 9.38 39,266
2021-01-25 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,375 67.03 92,171
2021-01-25 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,375 11.02 15,152
2021-01-01 Schall Thomas J. (President and CEO) Option Ex 87,899 .00 0
2021-01-01 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 21,100 .00 0
2021-01-01 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 30,333 .00 0
2020-12-28 Edwards Thomas A. (Director) Sale 10,782 61.50 663,093
2020-12-24 Edwards Thomas A. (Director) Sale 14,218 61.18 869,899
2020-12-15 Kwan Pui San (Principal Acctg Officer) Sale 42,593 65.06 2,771,228
2020-12-15 Kwan Pui San (Principal Acctg Officer) Option Ex 42,593 9.38 399,735
2020-12-15 Schall Thomas J. (President and CEO) Sale 17,619 65.01 1,145,446
2020-12-15 Schall Thomas J. (President and CEO) Option Ex 17,619 14.31 252,127
2020-12-14 Kwan Pui San (Principal Acctg Officer) Sale 8,957 65.02 582,402
2020-12-14 Kwan Pui San (Principal Acctg Officer) Option Ex 8,957 7.07 63,325
2020-12-14 Schall Thomas J. (President and CEO) Sale 11,153 65.03 725,246
2020-12-14 Schall Thomas J. (President and CEO) Option Ex 11,153 14.31 159,599
2020-08-03 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 49,258 53.71 2,645,450
2020-07-31 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 40,402 52.88 2,136,417
2020-07-30 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 48,081 54.22 2,606,807
2020-07-29 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 88,012 52.45 4,616,405
2020-07-28 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 40,160 53.78 2,159,804
2020-07-27 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 34,236 53.41 1,828,578
2020-07-24 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 26,050 52.92 1,378,487
2020-07-23 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 34,555 55.00 1,900,594
2020-07-22 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 72,469 55.65 4,032,899
2020-07-21 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 87,529 55.82 4,885,956
2020-07-20 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 54,598 55.94 3,054,157
2020-07-17 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 47,890 56.28 2,695,297
2020-07-16 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 73,500 57.33 4,213,975
2020-07-15 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 86,298 59.04 5,094,775
2020-07-14 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 100,000 57.90 5,789,700
2020-07-13 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 100,000 58.77 5,876,800
2020-07-10 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 45,844 60.05 2,752,748
2020-07-09 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 100,000 60.73 6,073,100
2020-07-08 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 100,000 60.28 6,028,500
2020-07-07 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 79,387 58.88 4,674,544
2020-07-06 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 86,690 58.74 5,092,257
2020-07-02 Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) Sale 87,781 57.28 5,027,832
2020-06-15 Schall Thomas J. (President and CEO) Sale 2,000 65.05 130,090
2020-06-15 Schall Thomas J. (President and CEO) Option Ex 2,000 14.31 28,620
2020-06-12 Schall Thomas J. (President and CEO) Sale 88,753 65.08 5,775,867
2020-06-12 Schall Thomas J. (President and CEO) Option Ex 88,753 14.31 1,270,055
2020-06-12 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 33,541 65.10 2,183,519
2020-06-12 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 33,541 10.86 364,255
2020-06-12 Kanaya Susan M (EVP, CFO and Sec.) Sale 50,000 64.58 3,229,050
2020-06-12 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 50,000 9.61 480,250
2020-06-03 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 10,750 5.47 58,834
2020-05-26 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 19,612 60.34 1,183,427
2020-05-26 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 19,612 6.62 129,831
2020-05-23 Parker Geoffrey M. (Director) Option Ex 7,724 .00 0
2020-05-23 Tyree James L (Director) Option Ex 7,724 .00 0
2020-05-22 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 40,867 60.06 2,454,512
2020-05-22 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 40,867 6.62 270,539
2020-05-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 2,800 59.99 167,986
2020-05-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 2,800 6.62 18,536
2020-05-12 Schall Thomas J. (President and CEO) Sale 35,865 57.75 2,071,096
2020-05-12 Schall Thomas J. (President and CEO) Option Ex 35,865 14.31 513,228
2020-05-11 Schall Thomas J. (President and CEO) Sale 70,608 55.73 3,935,336
2020-05-11 Schall Thomas J. (President and CEO) Option Ex 70,608 14.31 1,010,400
2020-05-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 34,222 55.12 1,886,145
2020-05-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 34,222 3.57 122,172
2020-05-08 Schall Thomas J. (President and CEO) Sale 4,201 55.01 231,113
2020-05-08 Schall Thomas J. (President and CEO) Option Ex 4,201 14.31 60,116
2020-05-08 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 4,312 50.01 215,638
2020-05-08 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 4,312 3.57 15,393
2020-05-05 Schall Thomas J. (President and CEO) Sale 8,851 55.01 486,849
2020-05-05 Schall Thomas J. (President and CEO) Option Ex 8,851 14.31 126,657
2020-05-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 8,860 55.01 487,344
2020-05-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 8,860 3.57 31,630
2020-05-05 Kanaya Susan M (EVP, CFO and Sec.) Sale 20,123 54.73 1,101,231
2020-05-05 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 20,123 8.19 164,807
2020-05-04 Kanaya Susan M (EVP, CFO and Sec.) Sale 54,877 54.57 2,994,802
2020-05-04 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 54,877 8.19 449,442
2020-03-27 Jain Rita (Director) Option Ex 5,251 .00 0
2020-03-23 Parker Geoffrey M. (Director) Sale 30,000 36.41 1,092,450
2020-03-04 Schall Thomas J. (President and CEO) Sale 40,844 50.35 2,056,699
2020-03-04 Schall Thomas J. (President and CEO) Option Ex 40,844 14.31 584,477
2020-02-20 Schall Thomas J. (President and CEO) Sale 15,341 50.66 777,098
2020-02-20 Schall Thomas J. (President and CEO) Option Ex 15,341 14.31 219,529
2020-02-19 Schall Thomas J. (President and CEO) Sale 63,340 50.77 3,216,088
2020-02-19 Schall Thomas J. (President and CEO) Option Ex 63,340 14.31 906,395
2020-02-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 42,631 50.67 2,159,942
2020-02-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 42,631 8.19 349,147
2020-02-19 Kanaya Susan M (EVP, CFO and Sec.) Sale 24,200 50.34 1,218,300
2020-02-19 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 24,200 10.86 262,812
2020-02-13 Kanaya Susan M (EVP, CFO and Sec.) Sale 45,300 49.61 2,247,151
2020-02-13 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 45,300 9.53 431,482
2020-02-12 Kanaya Susan M (EVP, CFO and Sec.) Sale 2,500 49.51 123,775
2020-02-12 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 2,500 9.53 23,812
2020-02-11 Kwan Pui San (Principal Acctg Officer) Sale 18,941 49.15 930,893
2020-02-11 Kanaya Susan M (EVP, CFO and Sec.) Sale 3,000 49.50 148,509
2020-02-11 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 3,000 9.53 28,575
2020-02-06 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 36,850 47.31 1,743,336
2020-02-06 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 36,850 8.19 301,801
2020-02-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 13,150 47.03 618,457
2020-02-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 13,150 8.19 107,698
2020-02-04 Schall Thomas J. (President and CEO) Sale 119,525 45.19 5,400,737
2020-02-04 Schall Thomas J. (President and CEO) Option Ex 119,525 14.31 1,710,402
2020-02-04 Kanaya Susan M (EVP, CFO and Sec.) Sale 99,617 45.09 4,492,228
2020-02-04 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 99,617 14.31 1,425,519
2020-02-03 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 48,471 44.47 2,155,505
2020-02-03 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 48,471 8.19 396,977
2020-02-03 Kanaya Susan M (EVP, CFO and Sec.) Sale 3,837 44.91 172,315
2020-02-03 Kanaya Susan M (EVP, CFO and Sec.) Option Ex 3,837 14.31 54,907
2020-01-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,259 44.00 55,392
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CCXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chemocentryx, Inc. (symbol CCXI, CIK number 1340652) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.